APA (7th ed.) Citation

L, P., K, K., BC, M., M, B., N, K., J, E., . . . M, A. (2023). CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia. Frontiers in oncology, 13, 1150149. https://doi.org/10.3389/fonc.2023.1150149

Chicago Style (17th ed.) Citation

L, Pousse, et al. "CD25 Targeting with the Afucosylated Human IgG1 Antibody RG6292 Eliminates Regulatory T Cells and CD25+ Blasts in Acute Myeloid Leukemia." Frontiers in Oncology 13 (2023): 1150149. https://doi.org/10.3389/fonc.2023.1150149.

MLA (9th ed.) Citation

L, Pousse, et al. "CD25 Targeting with the Afucosylated Human IgG1 Antibody RG6292 Eliminates Regulatory T Cells and CD25+ Blasts in Acute Myeloid Leukemia." Frontiers in Oncology, vol. 13, 2023, p. 1150149, https://doi.org/10.3389/fonc.2023.1150149.